James L. Speyer
- Oncology top 1%
- Cardiology and Cardiovascular Medicine top 2%
- Surgery top 5%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Charles E. MyersJerry M. CollinsHoward S. HöchsterJean JenkinsFranco M. MuggiaRobert L. DedrickRaymond F. GreeneAnne Zeleniuch‐Jacquotte
- Topics
- Cancer Treatment and Pharmacology (35 papers)Ovarian cancer diagnosis and treatment (23 papers)Chemotherapy-induced cardiotoxicity and mitigation (22 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologyJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
James L. Speyer
93 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 113
- Oncology 2.2k
- Cardiology and Cardiovascular Medicine 1.2k
- Surgery 1.0k
- Molecular Biology 928
- Pulmonary and Respiratory Medicine 788
Countries citing papers authored by James L. Speyer
This map shows the geographic impact of James L. Speyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Speyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Speyer more than expected).
Fields of papers citing papers by James L. Speyer
This network shows the impact of papers produced by James L. Speyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Speyer. The network helps show where James L. Speyer may publish in the future.
Co-authorship network of co-authors of James L. Speyer
This figure shows the co-authorship network connecting the top 25 collaborators of James L. Speyer. A scholar is included among the top collaborators of James L. Speyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Speyer. James L. Speyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 18 | |
| 4 | 184 | |
| 5 | 8 | |
| 6 | 56 | |
| 7 | 4 | |
| 8 | 4 | |
| 9 | Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study. | 49 |
| 10 | 466 | |
| 11 | 45 | |
| 12 | 8 | |
| 13 | 6 | |
| 14 | 20 | |
| 15 | 11 | |
| 16 | 9 | |
| 17 | 32 | |
| 18 | 1 | |
| 19 | 65 | |
| 20 | 20 |
About James L. Speyer
James L. Speyer is a scholar working on Reproductive Medicine, Oncology and Dermatology, having authored 94 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (35 papers), Ovarian cancer diagnosis and treatment (23 papers) and Chemotherapy-induced cardiotoxicity and mitigation (22 papers). The work is most often cited by research in Oncology (2.2k citations), Reproductive Medicine (669 citations) and Cardiology and Cardiovascular Medicine (1.2k citations). James L. Speyer has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Charles E. Myers, Jerry M. Collins, Howard S. Höchster, Jean Jenkins, Franco M. Muggia, Robert L. Dedrick, Raymond F. Greene, Anne Zeleniuch‐Jacquotte, J Wernz and Paul H. Sugarbaker. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.